Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Medical & Biological Engineering & Computing|January 1, 1997
Dimensions and mechanical properties of porcine aortic segments determined by combined impedance planimetry and high-frequency ultrasoundJ H Storkholm, G E Villadsen, K Krogh, et al.
Scandinavian Journal of Gastroenterology|September 14, 2007
Gastric emptying: a comparison of three methodsHenning Glerup, Henrik Bluhme, Gerda E Villadsen, et al.
Journal of Hepatology|June 9, 2020
Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosisPeter Jepsen, Frederik Kraglund, Joe West, et al.
Digestive Diseases and Sciences|January 16, 2007
Biomechanical remodeling of the chronically obstructed Guinea pig small intestineJan Henrik Storkholm, Jingbo Zhao, Gerda E Villadsen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 10, 2019
[18 F]-Fluoro-2-deoxy-D-galactose positron emission tomography/computed tomography as complementary imaging tool in patients with hepatocellular carcinomaKirstine P Bak-Fredslund, Susanne Keiding, Gerda E Villadsen, et al.
Hepatology Communications|January 12, 2023
Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trialsFrederik Kraglund, Diana H Christensen, Andreas H Eiset, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2014
The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver diseaseKasper S Mikkelsen, Michael Sørensen, Kim Frisch, et al.
British Journal of Cancer|February 6, 2003
Breast cancer incidence after the start of mammography screening in DenmarkA H Olsen, A Jensen, S H Njor, et al.
EJNMMI Research|August 31, 2017
Metabolic liver function in humans measured by 2-18F-fluoro-2-deoxy-D-galactose PET/CT-reproducibility and clinical potentialKirstine P Bak-Fredslund, Peter Lykke Eriksen, Ole L Munk, et al.
Clinical Transplantation|January 3, 2013
Long-term outcome in patients treated with combined heart and liver transplantation for familial amyloidotic cardiomyopathyLaerke M Nelson, Luit Penninga, Kaare Sander, et al.
Pageof 5